7-Methoxy-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 5g

1-((4'-chloro-[1,1'-biphenyl])-4-sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 250mg

(S)-tert-Butyl 4-isopropyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 98%, 250mg

[2,3'-Bipyridin]-6-ylmethanol, 95%, 100mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 250mg

N-Methoxy-N-methylpyrazine-2-carboxamide, 97%, 5g

4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)morpholine, 95.0%, 1g

N,N-Dimethyl-2-phenoxyethanamine, 95.0%, 100g

[2-methanesulfonyl-1-(prop-2-en-1-yl)-1H-imidazol-5-yl]methanol, 95.0%, 10g

(1R-trans)-Methyl 3-hydroxycyclohexanecarboxylate, 98%, 100mg

5-Methyl-3-phenyl-isoxazole-4-carboxylic acid, 98.0%, 1g

Plateaux d'incubation occidentaux, MIDI-XL, 1 pièce

(4'-Fluoro-[1,1'-biphenyl]-4-yl)methanaminehydrochloride, 95%, 250mg